Micron Biomedical

Healthcare & Life Sciences

Recent Finacing

Non-dilutive financing

Recent Raise

$7.5M

Micron Biomedical develops needle-free microarray technology to improve vaccine access and address hesitancy, particularly for the measles-rubella vaccine.

Total Funding

$7.5M

Headquarters

N/A

Founded

N/A

Website

micronbiomedical.com

Focus Areas

Needle-free

Microarray technology

Vaccine delivery

Measles-rubella

Manufacturing scale-up

Global health

Investors